Secondary leukemias induced by topoisomerase-targeted drugs (Q77333785)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748598 AND SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Secondary leukemias induced by topoisomerase-targeted drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748598 AND SRC:MED&resulttype=core&format=json

4 December 2019

author name string

C A Felix

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748598 AND SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748598 AND SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748598 AND SRC:MED&resulttype=core&format=json

4 December 2019

volume

1400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748598 AND SRC:MED&resulttype=core&format=json

4 December 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748598 AND SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

233-255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748598 AND SRC:MED&resulttype=core&format=json

The secondary leukemias: challenges and research directions

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute lymphoblastic leukaemia with t(4;11) follows neuroblastoma: a late effect of treatment?

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Myeloid neoplasia in children treated for solid tumours

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute nonlymphocytic leukemia after treatment of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Translocation (9;11)(p21;q23) in a child with acute monoblastic leukemia following 2 1/2 years after successful chemotherapy for neuroblastoma

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Secondary leukaemias after etoposide

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Secondary leukaemia after epipodophyllotoxins

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Secondary Leukemia Associated With a Conventional Dose of Etoposide: Review of Serial Germ Cell Tumor Protocols

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute Nonlymphocytic Leukemia in Germ Cell Tumor Patients Treated With Etoposide-Containing Chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute Leukemia after Successful Chemotherapy for Oat Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Secondary neoplasms following treatment of malignant germ cell tumors

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute leukemia in a patient with ovarian cancer treated with cisplatin-based chemotherapy and alkeran

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Leukemia following chemotherapy for ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan)

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Leukemia after therapy with alkylating agents for childhood cancer

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Melphalan may be a more potent leukemogen than cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The cellular functions of small GTP-binding proteins

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Signal transduction through small GTPases—A tale of two GAPs

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The GTPase superfamily: a conserved switch for diverse cell functions

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The GTPase superfamily: conserved structure and molecular mechanism

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Proteins regulating Ras and its relatives

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute promyelocytic leukemia following treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Favorable cytogenetic abnormalities in secondary leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Specific chromosome changes and nonoccupational exposure to potentially carcinogenic agents in acute leukemia in China

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The association of specific "favorable" cytogenetic abnormalities with secondary leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute leukemia in association with Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Secondary acute myelogenous leukemia following safe exposure to etoposide

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

1 reference

7 January 2021

DNA topoisomerases: essential enzymes and lethal targets

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Structure and mechanism of DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Study of allosteric communication between protomers by immunotagging

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The role of DNA topoisomerases in recombination and genome stability: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Topoisomerases in human disease

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Integration of simian virus 40 into cellular DNA occurs at or near topoisomerase II cleavage hot spots induced by VM-26 (teniposide).

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Disruption of a topoisomerase-DNA cleavage complex by a DNA helicase

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Chromosome aberrations induced by etoposide (VP-16) are not random

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Small deletion and insertion mutations induced by the topoisomerase II inhibitor teniposide in CHO cells and comparison with sites of drug-stimulated DNA cleavage in vitro

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Cloning and characterization of the t(X;11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23)

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Altered Hox expression and segmental identity in Mll-mutant mice

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

ALL-1 partial duplication in acute leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Sequence specific generation of a DNA panhandle permits PCR amplification of unknown flanking DNA

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

RAS mutations in pediatric leukemias with MLL gene rearrangements

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Causes of Childhood Leukemia Beginning To Emerge

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Exposure of infants to phyto-oestrogens from soy-based infant formula

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Characterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Characterization of a Fusion cDNA (RARA/myl) Transcribed from the t(15;17) Translocation Breakpoint in Acute Promyelocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Role of the histone deacetylase complex in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Thymocyte apoptosis induced by p53-dependent and independent pathways.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

p53-catalyzed annealing of complementary single-stranded nucleic acids

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

p53 Protein exhibits 3'-to-5' exonuclease activity

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

p53 gene mutations in pediatric brain tumors

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Potential role for wild-type p53 in leukemias with MLL gene translocations

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Mechanism of action of antitumor drug etoposide: a review

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded phi X174 DNA.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Repair of oxidative damage to DNA: enzymology and biology

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Histidine 289 is essential for hydrolysis of the alkyl-enzyme intermediate of haloalkane dehalogenase

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Apurinic sites are position-specific topoisomerase II poisons.

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Spontaneous DNA damage stimulates topoisomerase II-mediated DNA cleavage

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Therapy of secondary acute nonlymphocytic leukemia with cytarabine

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia. Club de Réflexion en Hématologie

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Transient therapy-related myelodysplastic syndrome associated with monosomy 7 and 11q23 translocation

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Retinoids in cancer therapy

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

Topoisomerase inhibitors. A review of their therapeutic potential in cancer

1 reference

https://api.crossref.org/works/10.1016/S0167-4781(98)00139-0

7 January 2021

10.1016/S0167-4781(98)00139-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9748598 AND SRC:MED&resulttype=core&format=json

4 December 2019

1 reference